17.09.20: Credit Suisse Annual Virtual Basic Materials Conference
Credit Suisse Annual Virtual Basic Materials ConferenceLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 28, 2020 Category: Pharmaceuticals Source Type: news
21.09.20: Berenberg and Goldman Sachs Virtual German Corporate Conference
Berenberg and Goldman Sachs Virtual German Corporate ConferenceLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 28, 2020 Category: Pharmaceuticals Source Type: news
23.09.20: Bernstein Virtual Strategic Decision Conference
Bernstein Virtual Strategic Decision ConferenceLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 28, 2020 Category: Pharmaceuticals Source Type: news
24.09.20: Bernstein Virtual Strategic Decision Conference
Bernstein Virtual Strategic Decision ConferenceLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 28, 2020 Category: Pharmaceuticals Source Type: news
28.08.20: Not intended for U.S. and UK Media
Bayer submits vericiguat for marketing authorization in China for the treatment of chronic heart failuremehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 28, 2020 Category: Pharmaceuticals Source Type: news
27.08.20: Bayer and Northpond Ventures lead USD 55 million Series A financing round for Triumvira Immunologics
Bayer and Northpond Ventures lead USD 55 million Series A financing round for Triumvira ImmunologicsLeaps by Bayer and Northpond Ventures co-lead the investment to support development of next-generation immuno oncology treatments / Triumvira's T-cell therapies have transformative potential as a new type of cancer treatment that uses the immune system to fight cancer / Pipeline includes four therapeutic candidates for both autologous and allogeneic T-cell immuno therapies for treatment of liquid and solid tumorsmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 27, 2020 Category: Pharmaceuticals Source Type: news
27.08.20: Not intended for U.S. and UK Media
Bayer receives approval for Xofigo® in Chinamehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 26, 2020 Category: Pharmaceuticals Source Type: news
24.08.20: Bayer and Informed Data Systems Inc. (One Drop) join forces to jointly develop digital health products across therapeutic areas
Bayer and Informed Data Systems Inc. (One Drop) join forces to jointly develop digital health products across therapeutic areasDeal value up to USD 98 million including increased equity stake and joint development of digital health platform / Collaboration reinforces Bayer's commitment to developing integrated care solutions for patientsmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 24, 2020 Category: Pharmaceuticals Source Type: news
17.09.20: ESG Investor Conference Call
ESG Investor Conference CallLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 21, 2020 Category: Pharmaceuticals Source Type: news
21.08.20: More than 950 companies join in the fight against climate change
Science Based Targets initiative endorses climate protection targets of Bayer AGImportant step in Bayer becoming climate-neutral by 2030 / Targets integral to Board of Management remunerationmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 21, 2020 Category: Pharmaceuticals Source Type: news
20.08.20: Bayer announces resolution of U.S. Essure™ claims
Bayer announces resolution of U.S. Essure™ claimsmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 20, 2020 Category: Pharmaceuticals Source Type: news
12.08.20: Bayer and Temasek unveil innovative new company focused on developing breakthroughs in vertical farming
Bayer and Temasek unveil innovative new company focused on developing breakthroughs in vertical farmingInitial efforts will focus on innovating vegetable varieties that deliver optimized quality and sensory experience / Called Unfold, the new company will be headquartered in the Davis, Calif., area with key operations in both the U.S. and Singapore / John Purcell appointed as CEOmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 13, 2020 Category: Pharmaceuticals Source Type: news
11.08.20: Not intended for U.S. and UK Media
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd.Further expansion of Bayer's drug development pipeline in Women's Healthcare / Innovative non-hormonal oral compound NT-814 to alleviate menopausal symptoms / Development compound recently completed Phase IIb / Reinforces Bayer's position in Women's Healthcare / Upfront consideration of USD 425 million and additional potential consideration in the form of milestone paymentsmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 10, 2020 Category: Pharmaceuticals Source Type: news
05.08.20: Post Q2 Virtual Roadshow
Post Q2 Virtual RoadshowLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 4, 2020 Category: Pharmaceuticals Source Type: news
04.08.20: Second quarter of 2020:
Bayer: Solid performance despite COVID-19 impactEnsuring employee safety and maintaining supply chains remain top priorities / Group sales decline by 2.5 percent (Fx & portfolio adj.) to 10.054 billion euros / EBITDA before special items up 5.6 percent to 2.883 billion euros / Crop Science reports operational growth / Sales and earnings at Pharmaceuticals down mainly due to volume-based procurement policy in China and COVID-19 / Sales at Consumer Health decline slightly (Fx & portfolio adj.) after strong demand in first quarter / Net loss of 9.548 billion euros due to special items for litigations - agreements in major leg...
Source: Bayer IR Newsfeed: Events - August 4, 2020 Category: Pharmaceuticals Source Type: news
